The effect of MX-1 on survival of discordant cardiac xenografts from guinea pig to rat.
Kaji
H
H
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Platt
J L
JL
Sutherland
D E
DE
Inoue
K
K
Mori
C
C
Shiota
K
K
Imamura
M
M
D000818:Animals; D003182:Complement C5 / Q000037:antagonists & inhibitors; D003169:Complement Inactivator Proteins / Q000494:pharmacology*; D004546:Elapid Venoms / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology*; D007150:Immunohistochemistry; D051381:Rats; D011917:Rats, Inbred Lew; D011951:Receptors, Complement / Q000276:immunology; D012717:Sesquiterpenes / Q000494:pharmacology*; D014183:Transplantation, Heterologous / Q000009:adverse effects / Q000276:immunology*
D003182:Complement C5; D003169:Complement Inactivator Proteins; D004546:Elapid Venoms; D011951:Receptors, Complement; D012717:Sesquiterpenes; C016310:cobra venom factor; C082885:soluble complement inhibitor 1; C038797:K 76 carboxylic acid